Aurora Sky and Aurora Sun

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on: 
Monday, November 7, 2022
Transaction, CSE, BCU, Timeline of cannabis laws in the United States, Editorial, Wind, Marketing, Bias, Driving under the influence, Social media, Cannabis, Partnership, Acquisition, Technology, Program, IMC, Disclosure, Company, MNI - Market News, Awareness, Fluid mechanics, Privacy policy, ACB, Plasma, Urine, ANY, CEO, Police, Vegetable, Use, Advertising, Patient, Blood, User experience, Leadership, Research, Saliva, Tilray, Sale, Smoking, OTC, Method, Privacy, Policy, Aurora Sky and Aurora Sun, Adjustment, THC, Nonmotorized Transportation Pilot Program, Goal, Contextual advertising, News, Time, Industry, Legislation, Financial News, USD, NASDAQ, Drug, Public relations, Politics, Bevo, Aphria

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points: 
  • Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
  • While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
  • The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
  • The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on: 
Monday, November 7, 2022
Transaction, CSE, BCU, Timeline of cannabis laws in the United States, Editorial, Wind, Marketing, Bias, Driving under the influence, Social media, Cannabis, Partnership, Acquisition, Technology, Program, IMC, Disclosure, Company, MNI - Market News, Awareness, Fluid mechanics, Privacy policy, ACB, Plasma, Urine, ANY, CEO, Police, Vegetable, Use, Advertising, Patient, Blood, User experience, Leadership, Research, Saliva, Tilray, Sale, Smoking, OTC, Method, Privacy, Policy, Aurora Sky and Aurora Sun, Adjustment, THC, Nonmotorized Transportation Pilot Program, Goal, Contextual advertising, News, Time, Industry, Legislation, Financial News, USD, NASDAQ, Drug, Public relations, Politics, Bevo, Aphria

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points: 
  • Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
  • While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
  • The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
  • The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on: 
Tuesday, October 11, 2022
Method, Aurora Sky and Aurora Sun, Transaction, Vegetable, Smoking, NASDAQ, Contextual advertising, Social media, Instagram, Program, CEO, Adjustment, Canopy Growth, Wind, OTC, Advertising, ACB, Metabolism, Privacy, Policy, News, Use, Privacy policy, Tilray, Twitter, Company, Marketing, Disclosure, Fig, City, Growth, Particle-size distribution, Editorial, Canopy, Research, Collection, Technology, Goal, Blood, CSE, Ecosystem, MNI - Market News, Sale, BCU, Bias, Patient, Financial News, Partnership, UCLA, Acquisition, THC, Plasma, NBC News, USD, Drug, Pharmaceutical industry, Medical device, Public relations, Bevo, Jetty, Aphria, Politics, Lemurian

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points: 
  • Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
    While cannabis legalization is expanding so does the need for better regulations.
  • Cannabix has participated in two testing day events held in two different US cities in June and July.
  • Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on: 
Tuesday, October 11, 2022
Method, Aurora Sky and Aurora Sun, Transaction, Vegetable, Smoking, NASDAQ, Contextual advertising, Social media, Instagram, Program, CEO, Adjustment, Canopy Growth, Wind, OTC, Advertising, ACB, Metabolism, Privacy, Policy, News, Use, Privacy policy, Tilray, Twitter, Company, Marketing, Disclosure, Fig, City, Growth, Particle-size distribution, Editorial, Canopy, Research, Collection, Technology, Goal, Blood, CSE, Ecosystem, MNI - Market News, Sale, BCU, Bias, Patient, Financial News, Partnership, UCLA, Acquisition, THC, Plasma, NBC News, USD, Drug, Pharmaceutical industry, Medical device, Public relations, Bevo, Jetty, Aphria, Politics, Lemurian

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points: 
  • Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
    While cannabis legalization is expanding so does the need for better regulations.
  • Cannabix has participated in two testing day events held in two different US cities in June and July.
  • Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

A Market Leader Expands With Innovative CBD Gummy Line

Retrieved on: 
Thursday, September 15, 2022
Nicotine, MSC, Human, Legislation, Oil, Industry, Canopy Growth, Government, Patient, U.S. Securities and Exchange Commission, OTC, Aurora Cannabis, Wine, NASDAQ, Restaurant, Power purchase agreement, Animal, Annual report, THC, Purchasing, TYSON, Sale, Securities Act of 1933, Tobacco, ACB, Company, Wine & Spirits, NOT, Hoist, Culture, Love, Form 10-K, News, Review, Partnership, Forward-looking statement, Smokeless tobacco, Security (finance), Securities Exchange Act of 1934, Smoke, TSX, ANY, Article, CBN, Private Securities Litigation Reform Act, Program, Southern Glazer's Wine and Spirits, Tilray, Solution, Cannabis, FNM, Smoking, Union, Awareness, Vegetable, Retail, Financial adviser, Bevo, EU, Aphria, Aurora Sky and Aurora Sun, CBD, Author

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line. Desperate for a good night's rest, more consumers are turning to CBD and CBN gummies for their sleep issues, especially as natural wellness trends have increased since the pandemic. Various cannabinoid products are available from the well-known industry developer and manufacturer of organic cannabinoid products in the form of oils (for humans and animals) and herbal capsules. To meet the growing consumer demand, cannabis companies Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), HEXO Corp (TSX:HEXO) (NASDAQ:HEXO), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY), and Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) are also expanding their CBD products line.

Key Points: 
  • NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line.
  • "Penetrating the US$261 billion tobacco products market in Europe is one of our top priorities."
  • The business created by Hoist and Hempshire U.S. union is well-positioned to dominate the market for tobacco- and nicotine-free smoking alternatives.
  • On August 15, Martha Stewart CBD's line of CBD gummies unveiled a new flavour - Pumpkin Spice CBD Wellness Gummies.

A Market Leader Expands With Innovative CBD Gummy Line

Retrieved on: 
Thursday, September 15, 2022
Nicotine, MSC, Human, Legislation, Oil, Industry, Canopy Growth, Government, Patient, U.S. Securities and Exchange Commission, OTC, Aurora Cannabis, Wine, NASDAQ, Restaurant, Power purchase agreement, Animal, Annual report, THC, Purchasing, TYSON, Sale, Securities Act of 1933, Tobacco, ACB, Company, Wine & Spirits, NOT, Hoist, Culture, Love, Form 10-K, News, Review, Partnership, Forward-looking statement, Smokeless tobacco, Security (finance), Securities Exchange Act of 1934, Smoke, TSX, ANY, Article, CBN, Private Securities Litigation Reform Act, Program, Southern Glazer's Wine and Spirits, Tilray, Solution, Cannabis, FNM, Smoking, Union, Awareness, Vegetable, Retail, Financial adviser, Bevo, EU, Aphria, Aurora Sky and Aurora Sun, CBD, Author

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line. Desperate for a good night's rest, more consumers are turning to CBD and CBN gummies for their sleep issues, especially as natural wellness trends have increased since the pandemic. Various cannabinoid products are available from the well-known industry developer and manufacturer of organic cannabinoid products in the form of oils (for humans and animals) and herbal capsules. To meet the growing consumer demand, cannabis companies Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), HEXO Corp (TSX:HEXO) (NASDAQ:HEXO), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY), and Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) are also expanding their CBD products line.

Key Points: 
  • NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line.
  • "Penetrating the US$261 billion tobacco products market in Europe is one of our top priorities."
  • The business created by Hoist and Hempshire U.S. union is well-positioned to dominate the market for tobacco- and nicotine-free smoking alternatives.
  • On August 15, Martha Stewart CBD's line of CBD gummies unveiled a new flavour - Pumpkin Spice CBD Wellness Gummies.